SCHEMBL11289134

SCHEMBL11289134

c1ccc(SNc2nc(-c3ccccc3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.56
MAPT P10636 4/20 0.56
TDP1 Q9NUW8 1/20 0.56
ADORA1 P30542 11/20 0.49
ADORA3 P0DMS8 5/20 0.49
ADORA2A P29274 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ADORA2B P29275 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
GAA P10253 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310308 0.89 KDM4E (0.50) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24309613 0.87 MAPT (0.44) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24309283 0.86 TDP1 (0.46) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24309752 0.83 MAPK1 (0.57) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24309268 0.82 BPTF (0.44) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24310499 0.81 AGTR1 (0.39) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL11026995 0.79 IDH1 (0.44) MAPTTDP1ADORA1ADORA3ADORA2A
SCHEMBL24309918 0.79 MAPT (0.39) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24310507 0.77 AGTR1 (0.38) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24309748 0.76 L3MBTL1 (0.38) MAPTSMN1; SMN2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0065226-A2 Sulfenamides, process for their preparation, their utilisation as medicines and their preparation BAYER AG (DE) 1982-11-24 EP disclosed